Plain-English translation of NCT06439082 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help reduce the number of painful crises that people with sickle cell disease experience. In sickle cell disease, red blood cells can get stuck in blood vessels, causing severe pain and other complications. The study will compare how many crises occur in people who receive the new medication versus those who receive a placebo (a dummy treatment), to find out whether this treatment actually works.
Many people with sickle cell disease have frequent, unpredictable pain crises that seriously affect their quality of life and require emergency care. This trial exists to find out whether this new medication can help prevent or reduce these crises, and to make sure it is safe to use.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the new medication or a placebo, along with your regular sickle cell care. Both groups will continue any medications they are already taking. You will need to visit the study clinic multiple times over about a year to receive your treatment and have your health monitored, including tracking how many pain crises you experience during that time.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States